Outsourcing

Speeding Development and Manufacturing of Materials for Clinical Trials. Image: JHDT Productions/Stock.Adobe.com

Speeding Up the Clinical Trial Process

CDMOs adopt flexible processes for manufacturing investigational drug products.

Supporting the Industry During a Pandemic. Image: Chan2545/Stock.Adobe.com

A Dose of Support During a Pandemic

Outsourcing companies fill the gap in drug development and manufacturing.

Fill/Finish Challenges for COVID-19 Vaccines

Liquid and lyophilized forms and preparing for the large capacity present challenges.

Toxicology: Ensuring Drugs are Safe for People

March 01, 2021

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

March 01, 2021

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

Avid Bioservices Expands Biologics Manufacturing Capacity

February 22, 2021

The second phase of the Myford facility expansion in California will add upstream and downstream processing suites.

Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience

February 17, 2021

The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.

Quotient Sciences Acquires CDMO Arcinova

February 17, 2021

The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.

Avid Bioservices Enters Manufacturing Agreement with Humanigen for Lenzilumab

February 04, 2021

The CGMP manufacturing agreement will expand production of lenzilumab, a candidate for COVID-19 therapy, to support a potential emergency use authorization filing.

PathoQuest Joins CAACB Consortium as Viral Safety Expert

February 04, 2021

PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.

Meeting Fill/Finish Challenges for COVID-19 Vaccines

February 01, 2021

CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.

Nexelis Expands Bioanalytical Services with Bioanalytical Lab Acquisition

January 28, 2021

Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.

Almac Invests in Expanding Global Biologics Testing Solutions

January 28, 2021

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.